Alena Rudkouskaya

This study shows that VRAC blockers have off-target effects and cytotoxicity masked by serum albumin, suggesting they are not reliable for studying VRAC function.

This study uses fluorescence lifetime imaging to quantify TZM-HER2 binding and distribution in tumors with varying microenvironments, showing differences in drug delivery efficacy between cancer types.

This study evaluates contrast agents for photon-counting micro-CT in tumor xenografts, finding that Exitrone Nano 12000 provides better vasculature enhancement and consistency compared to ISOVUE-370.